trial · primary record
HB0025 Injection
First-line pMMR Endometrial Cancer
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 333 |
| Primary completion | 2031-06-26 |
| Primary endpoint | Progression-free survival (PFS) |
| Registry ID | NCT07902999 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:06.139Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07902999
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.